Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.87 USD | +1.41% | +3.99% | -39.19% |
May. 22 | Lee Health Selects Evolv Technology For Weapons Detection | CI |
May. 10 | Evolv Technology Shares Plunge After Full-Year Revenue Guidance Cut | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Communications & Networking
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-39.19% | 442M | - | ||
-6.13% | 41.96B | A- | ||
-4.95% | 10.72B | B | ||
-10.79% | 7.56B | A- | ||
+4.69% | 6.51B | C+ | ||
+14.13% | 3.18B | B | ||
+8.70% | 2.3B | A | ||
+51.12% | 1.85B | D | ||
+8.12% | 1.74B | - | C+ | |
+2.17% | 1.51B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- EVLV Stock
- Ratings Evolv Technologies Holdings, Inc.